Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Endocr Relat Cancer. 2016 Jul 18;23(9):739–746. doi: 10.1530/ERC-16-0246

Figure 1.

Figure 1

Cardiac myxoma and growth hormome (GH) excess in 99 patients with Carney Complex (CNC): 60.9% (n = 28 of 46) of the patients with GH excess had a cardiac myxoma, compared to 35.9% (n = 19 of 53) of those who did not have GH excess (p = 0.0160). Patients with a history of GH excess were more likely to develop a cardiac mass versus those without GH excess during their lifetime (OR = 2.78, 95% CI: 1.23–6.29, p = 0.0139).